Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AOC3 | Q16853 | 15/20 | 0.51 |
| ▸ | AOC2 | O75106 | 2/20 | 0.47 |
| ▸ | MAOB | P27338 | 2/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.42 |
| ▸ | MAOA | P21397 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21780087 | 0.96 | AOC3 (0.52) | AOC3AOC2MAOBCA1CA2 | |
| Trifluoroacetic Acid SCHEMBL30089516 | 0.88 | AOC3 (0.52) | AOC3AOC2MAOBCA1CA2 | |
| Trifluoroacetic Acid SCHEMBL21768084 | 0.88 | AOC3 (0.52) | AOC3AOC2MAOBCA1CA2 | |
| Trifluoroacetic Acid SCHEMBL21768080 | 0.88 | AOC3 (0.52) | AOC3AOC2MAOBCA1CA2 | |
| Trifluoroacetic Acid SCHEMBL21768159 | 0.88 | AOC3 (0.52) | AOC3AOC2MAOBCA1CA2 | |
| SCHEMBL21780142 | 0.82 | AOC2 (0.56) | AOC3AOC2MAOBCA1CA2 | |
| SCHEMBL21780132 | 0.82 | AOC2 (0.56) | AOC3AOC2MAOBCA1CA2 | |
| Trifluoroacetic Acid SCHEMBL21768119 | 0.82 | AOC2 (0.48) | AOC3AOC2MAOBMAOA | |
| SCHEMBL21780085 | 0.82 | CA1 (0.40) | AOC3MAOBCA1CA2CA7 | |
| Trifluoroacetic Acid SCHEMBL30089479 | 0.78 | HPGD (0.45) | AOC3CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110352188-B | Fluoroallylamine derivatives and use thereof | 四川科伦博泰生物医药股份有限公司 | 2022-11-29 | — | — | CN | disclosed |
| US-20200087248-A1 | Fluoroallylamine Derivative And Use Thereof | SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. (CN) | 2020-03-19 | — | — | US | disclosed |
| EP-3617186-A1 | FLUOROALLYLAMINE DERIVATIVE AND USE THEREOF | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (CN) | 2020-03-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200087248-A1 | Fluoroallylamine Derivative And Use Thereof | VAPB, VAPA, SLC28A1 | AOC3 6/4885AOC2 16/4885MAOB 60/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.